Causes and components of the metabolic syndrome in renal transplant recipients from a gender perspective.
[Causes and components of the metabolic syndrome in renal transplant recipients from a gender perspective]. Nutr Hosp. 2018 Oct 05;35(5):1079-1084 Authors: Martín Salvador A, Fernández Castillo R, García García I, Aguilar Cordero MJ, Bravo Soto J Abstract INTRODUCTION: the appearance of metabolic syndrome (MS) among renal recipients is one of the greatest post-transplant complications and is associated with an increased risk of graft failure and high rates of obesity and new onset diabetes. OBJECTIVE: the objective of this work is to identify the relationship between the glomerular filtration rate measured by two different methods and the components of the metabolic syndrome and their combinations in kidney transplant patients according to gender. MATERIAL AND METHOD: the samples consisted of 500 kidney transplant recipients, of whom 190 had MS, 121 men and 69 women. All subjects underwent clinical evaluation and blood sampling for laboratory measurements. The MS was determined according to the criteria of the National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP-III). Renal function was estimated using AMDRD equations and CrS determinations. RESULTS: the average age was 55.5 years. The prevalence of MS was significantly higher in men (23.1%
CONCLUSIONS In this Caribbean population, uncontrolled asthma was independently associated with obesity, late-onset disease, and comorbidities of sleep apnea and depression. Poor asthma-related quality of life was independently associated with Indo-Caribbean ethnicity. PMID: 32493146 [PubMed - as supplied by publisher]
Publication date: Available online 13 May 2020Source: Molecular MetabolismAuthor(s): Gaelle R. Carrat, Elizabeth Haythorne, Alejandra Tomas, Leena Haataja, Andreas Müller, Peter Arvan, Alexandra Piunti, Kaiying Cheng, Mutian Huang, Timothy J. Pullen, Eleni Georgiadou, Theodoros Stylianides, Nur Shabrina Amirruddin, Victoria Salem, Walter Distaso, Andrew Cakebread, Kate J. Heesom, Philip A. Lewis, David J. Hodson, Linford J. Briant
Publication date: Available online 4 June 2020Source: Pharmacological ResearchAuthor(s): Ying Huang, Changming Xie, Xiaoke Chen, Qianhui Hong, Hui Huang
Publication date: Available online 4 June 2020Source: Asian Journal of Pharmaceutical SciencesAuthor(s): Yannis V. Simos, Konstantinos Spyrou, Michaela Patila, Niki Karouta, Haralambos Stamatis, Dimitrios Gournis, Evangelia Dounousi, Dimitrios Peschos
Publication date: Available online 5 June 2020Source: Journal of Geriatric OncologyAuthor(s): Smith Giri, Madan Raj Aryal, Han Yu, Alyssa Grimshaw, Ranjan Pathak, Scott P. Huntington, Binod Dhakal
CONCLUSION: We conclude that visfatin in serum may be a new independent potential marker of AMI. PMID: 32495751 [PubMed - as supplied by publisher]
This study provides direct evidence for the contribution of gut microbiota to the cognitive decline during normal aging and suggests that restoring microbiota homeostasis in the elderly may improve cognitive function. On Nutraceutical Senolytics https://www.fightaging.org/archives/2020/05/on-nutraceutical-senolytics/ Nutraceuticals are compounds derived from foods, usually plants. In principle one can find useful therapies in the natural world, taking the approach of identifying interesting molecules and refining them to a greater potency than naturally occurs in order to produce a usefully large therape...
ConclusionThe transplant population has multiple cardiovascular risk factors. Early detection and correction of these factors must be a priority in order to improve the survival of these patients.
Conclusion: The obesity-related SNP rs545854 was correlated with the serum uric acid level and risk of hyperuricemia in a male Chinese population. Therefore, men carrying this SNP could benefit from limiting their meat consumption to prevent hyperuricemia. These findings suggest an underlying genetic link between obesity and hyperuricemia worthy of further exploration. Introduction Serum uric acid (SUA) is a final product of the metabolic breakdown of purine oxidation (1). Since humans lack the gene for uricase that converts uric acid into a soluble form, the human uric acid level tends to be higher than that of othe...
In this study, researchers analysed data of millions of British patients between 1995 and 2015 to see if this claim held true. They tracked people who were obese at the start of the study, defined as people with a body mass index (BMI) of 30 or more, who had no evidence of heart disease, high blood pressure, high cholesterol or diabetes at this point. They found these people who were obese but "metabolically healthy" were at higher risk of developing heart disease, strokes and heart failure than people of normal weight. No such thing as 'fat but fit', major study finds Several studies in the pas...
More News: Cardiology | Cardiovascular | Cholesterol | Diabetes | Eating Disorders & Weight Management | Education | Endocrinology | Heart | Hypertension | Kidney Transplant | Kidney Transplantation | Laboratory Medicine | Metabolic Syndrome | Nutrition | Obesity | Transplant Surgery | Transplants | Universities & Medical Training | Urology & Nephrology | Women